ARCHIVES

Bristol-Myers, Karolinska In Collaboration For Studies.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Committee Unblinds Phase III Zytiga Study

March 30, 2012

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006

RFP: Intellectual Property.

March 31, 2000

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001

Ford Gets Temporary Funds Bill; House Committee Demands More Positions for NCI

June 27, 1975

DCE Board Approve Concepts For Contract Recompetitions

November 23, 1984